᱒᱐᱑᱙-᱒᱐ ᱥᱮᱨᱢᱟ ᱨᱮ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱭᱟᱜ ᱡᱮᱜᱮᱫ ᱫᱳᱹᱨᱞᱚᱭ

ᱢᱟᱨᱟᱝ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱫᱳᱹᱨᱞᱚᱭ (᱒᱐᱑᱙-᱒᱐) ᱨᱮᱭᱟᱜ ᱮᱛᱚᱦᱚᱵ ᱫᱚ ᱢᱤᱫ ᱱᱟᱣᱟ ᱞᱮᱠᱟᱱ ᱠᱚᱨᱚᱱᱟ ᱧᱩᱛᱩᱢᱟᱱ ᱵᱷᱟᱭᱨᱟᱥ (2019-nCoV) ᱦᱚᱛᱮ ᱛᱮ ᱒᱐᱑᱙ ᱥᱮᱨᱢᱟ ᱨᱮᱭᱟᱜ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱪᱟᱱᱫᱚ ᱨᱮᱭᱟᱜ ᱛᱟᱞᱟ ᱢᱟᱞᱟ ᱠᱚ ᱨᱮ ᱪᱤᱱ ᱫᱤᱥᱚᱢ ᱨᱮᱭᱟᱜ ᱨᱮᱭᱟᱜ ᱵᱩᱦᱟᱱ ᱱᱟᱝᱜᱽᱨᱟᱦᱟ ᱨᱮ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱛᱮ ᱦᱚᱲ ᱠᱚ ᱡᱟᱹᱵᱽᱲᱤ ᱠᱟᱛᱮ ᱮᱛᱚᱦᱚᱵ ᱞᱮᱱᱟ᱾ ᱟᱭᱢᱟ ᱦᱚᱲ ᱵᱮᱜᱚᱨ ᱚᱡᱮ ᱛᱮ ᱱᱤᱢᱚᱱᱤᱭᱟ ᱧᱟᱢ ᱠᱮᱫ ᱠᱚᱣᱟ, ᱡᱟᱹᱵᱽᱲᱤ ᱟᱠᱟᱱ ᱦᱚᱲ ᱠᱚ ᱢᱩᱫᱽ ᱨᱮ ᱰᱷᱮᱨ ᱦᱚᱲ ᱜᱮ ᱦᱩᱣᱟᱱ ᱱᱟᱝᱜᱽᱨᱟᱦᱟ ᱨᱮᱭᱟᱜ ᱥᱤ-ᱯᱷᱩᱰ ᱵᱟᱡᱟᱨ ᱦᱟᱠᱚ ᱟᱹᱠᱷᱨᱤᱧ ᱠᱚᱠᱚ ᱛᱟᱦᱮᱸ ᱠᱟᱱᱟ, ᱢᱮᱛᱟᱜ ᱢᱮ ᱮᱴᱟᱜ ᱡᱤᱣᱮᱫ ᱡᱟᱱᱟᱣᱟᱨ ᱠᱚᱠᱚ ᱟᱹᱠᱷᱨᱤᱧᱮᱫ ᱠᱚ ᱛᱟᱦᱮᱸᱠᱟᱱᱟ᱾ ᱪᱤᱱ ᱫᱤᱥᱚᱢ ᱨᱮᱱ ᱥᱟᱬᱮᱥᱤᱭᱟᱹ ᱠᱚ ᱛᱟᱭᱱᱚᱢ ᱛᱮ, ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱧᱩᱛᱟᱢᱟᱱ ᱱᱟᱣᱟ ᱡᱤᱣ ᱯᱤᱞᱤᱧ ᱡᱮᱞᱮᱠᱟ- 2019-nCoV ᱧᱟᱢ ᱩᱨᱩᱢ ᱠᱮᱫ ᱠᱚᱣᱟ, ᱟᱨ ᱱᱚᱣᱟ ᱧᱩᱛᱩᱢ ᱠᱚ ᱮᱢᱟᱫ ᱠᱚᱣᱟ᱾ ᱱᱩᱠᱩ ᱱᱟᱣᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮ ᱠᱚᱢ ᱛᱮ ᱠᱚᱢ ᱥᱟᱭ ᱠᱟᱲᱟ ᱗᱐% ᱩᱱᱠᱩ ᱡᱤᱣ ᱯᱤᱞᱤᱧ ᱨᱮᱱ ᱡᱷᱟᱲᱟ ᱛᱮᱫ ᱜᱮ ᱠᱚ ᱧᱟᱢ ᱮᱱᱟ; ᱚᱠᱚᱭ ᱫᱚ ᱥᱚᱨᱥ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮ ᱠᱚ ᱧᱟᱢᱚᱜ᱾ ᱡᱟᱹᱵᱽᱲᱤ ᱟᱠᱟᱱ ᱦᱚᱲ ᱠᱚ ᱵᱤᱰᱟᱹᱣ ᱩᱨᱩᱢ ᱠᱚ ᱞᱟᱹᱜᱤᱫ ᱢᱤᱫᱴᱮᱱ ᱠᱷᱟᱥ ᱠᱞᱤᱱᱤᱠᱮᱞ ᱯᱤ.ᱥᱤ.ᱟᱨ. ᱵᱤᱱᱤᱰᱟᱹᱣ ᱨᱮᱭᱟᱜ ᱩᱛᱱᱟᱹᱣ ᱥᱟᱶᱛᱮ ᱟᱭᱢᱟ ᱟᱡᱟᱨ ᱨᱮᱭᱟᱜ ᱯᱩᱥᱴᱟᱹᱣ ᱵᱟᱰᱟᱭᱮᱱᱟ, ᱡᱟᱹᱵᱽᱲᱤ ᱟᱠᱟᱱ ᱦᱚᱲ ᱠᱚ ᱢᱩᱫᱽ ᱨᱮ ᱰᱷᱮᱨ ᱦᱚᱲ ᱜᱮ ᱥᱤᱫᱷᱟᱹ ᱥᱤᱫᱷᱟᱹ ᱵᱟᱡᱟᱨ ᱥᱟᱶ ᱥᱟᱹᱜᱟ, ᱭ ᱛᱟᱦᱮᱸᱠᱟᱱ ᱛᱟᱠᱚᱣᱟ ᱟᱨ ᱩᱱᱠᱩ ᱦᱚᱲ ᱠᱚ ᱨᱮᱱ ᱦᱚᱸ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱭᱟᱜ ᱵᱟᱰᱟᱭ ᱧᱟᱢᱮᱱᱟ ᱚᱠᱚᱭ ᱠᱚ ᱫᱚ ᱥᱤᱫᱷᱟᱹ ᱵᱟᱡᱟᱨ ᱥᱟᱶ ᱡᱚᱲᱟᱣ ᱵᱟᱠᱚ ᱛᱟᱦᱮᱸᱠᱟᱱ᱾ ᱱᱤᱛ ᱦᱟᱹᱵᱤᱡ ᱛᱮ ᱯᱩᱥᱴᱟᱹᱣ ᱵᱟᱝ ᱵᱟᱰᱟᱭ ᱧᱟᱢ ᱟᱠᱟᱱ ᱡᱮ ᱱᱩᱠᱩ ᱵᱷᱟᱭᱨᱟᱥ ᱫᱚ ᱥᱚᱨᱥ ᱠᱚᱨᱚᱱᱟ ᱞᱮᱠᱟ ᱟᱹᱰᱤ ᱵᱟᱹᱲᱛᱤ ᱠᱚ ᱵᱚᱛᱚᱨᱟᱱᱟ ᱥᱮ ᱵᱟᱝ᱾

ᱢᱚᱦᱟᱢᱟᱨᱤ ᱥᱟᱬᱮᱥ (Epidemiology)
ᱜᱚᱡ/ᱵᱮᱱᱰᱟᱣ
ᱰᱟᱭᱜᱽᱨᱟᱢ

ᱪᱤᱱᱦᱟᱹ ᱠᱚ ᱟᱨ ᱞᱚᱠᱷᱭᱚᱬ ᱠᱚ (Signs and symptoms)
ᱱᱚᱣᱟ ᱠᱳᱵᱷᱤᱰ-᱑᱙ (COVID-19) ᱟᱡᱟᱨ ᱧᱟᱢ ᱟᱠᱟᱫᱮ ᱦᱚᱲ ᱴᱷᱮᱱ ᱛᱤᱱᱟ.ᱜ ᱞᱚᱠᱷᱭᱚᱬ ᱠᱚᱫᱚ ᱧᱮᱞᱚᱜ ᱜᱮᱭᱟ ᱟᱨ ᱛᱤᱱᱟ.ᱜ ᱜᱟᱱ ᱫᱚ ᱵᱟᱝ ᱜᱮ, ᱮᱱᱦᱚᱸ ᱧᱟᱢ ᱟᱠᱟᱫᱮ ᱦᱚᱲ ᱨᱩᱣᱟ., ᱠᱷᱩᱜ-ᱢᱟᱸᱫᱟ, ᱱᱤᱠᱟ.ᱥ ᱨᱮ ᱮᱴᱠᱮᱴᱚᱬᱮ ᱟᱨ ᱦᱚᱲᱢᱚ ᱛᱤ-ᱡᱟᱸᱜᱟ ᱞᱟᱸᱜᱟ ᱜᱮ ᱵᱩᱡᱷᱟ.ᱣᱟᱭ ᱾
ᱟᱡᱟᱨ ᱠᱳᱱᱴᱨᱳᱞ ᱟᱨ ᱫᱟᱯᱟᱨᱟᱢ (Centers for Disease Control and Prevention) ᱜᱟᱶᱛᱟ ᱫᱚ ᱡᱚᱨᱩᱨᱤᱠᱟᱲᱤᱱ ᱞᱚᱠᱷᱭᱚᱬ ᱠᱚᱭ ᱞᱤᱥᱴᱤ ᱫᱚᱦᱚᱭᱟ ᱾ ᱱᱤᱠᱟ.ᱥ ᱨᱮ ᱮᱴᱠᱮᱴᱚᱬᱮ,ᱠᱚᱲᱟᱢ ᱦᱟ.ᱥᱩ/ᱡᱚᱞᱟᱣ, ᱦᱚᱴᱷᱟᱛ ᱵᱟᱝ ᱦᱩᱫᱤᱥ ᱫᱟᱲᱮ, ᱢᱮᱸᱫᱦᱟ ᱟᱨ ᱞᱩᱴᱤ ᱞᱤᱞ ᱨᱚᱝ ᱮᱢᱟᱱ ᱞᱚᱠᱷᱭᱚᱬ ᱠᱚ ᱧᱮᱞᱮᱱ ᱠᱷᱟᱱ ᱞᱚᱜᱚᱱ ᱛᱤᱠᱪᱷᱟ. ᱞᱟ.ᱜᱤᱫ ᱫᱷᱭᱟᱱ ᱮᱢ ᱞᱟ.ᱠᱛᱤ ᱠᱟᱱᱟ ᱾
ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱵᱟ.ᱲᱛᱤ ᱤᱫᱤ ᱞᱮᱱᱠᱷᱟᱱ ᱦᱚᱲ ᱵᱟᱭ ᱨᱚᱲ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ,ᱱᱤᱠᱟ.ᱥ ᱦᱟᱛᱟᱣ ᱨᱮ ᱟ.ᱰᱤ ᱠᱚᱥᱴᱚ ᱟ.ᱭᱠᱟ.ᱣᱟ ᱟᱨ ᱜᱩᱨ ᱫᱟᱲᱮᱭᱟᱜ ᱜᱮᱭᱟᱭ ᱾ 
ᱱᱚᱣᱟ ᱞᱚᱠᱷᱭᱚᱬ ᱡᱮᱜᱮᱛ ᱦᱚᱲᱢᱚᱱ-ᱥᱟᱶᱟᱨ ᱜᱟᱶᱛᱟ (WHO) ᱒ ᱠᱷᱚᱱ ᱑᱐ ᱫᱤᱱ ᱟᱨ ᱟᱡᱟᱨ ᱠᱳᱱᱴᱨᱷᱳᱞ ᱟᱨ ᱫᱟᱯᱟᱨᱟᱢ (CDC), USA ᱒ ᱠᱷᱚᱱ ᱑᱔ ᱫᱤᱱ ᱵᱷᱤᱛᱤᱨ ᱨᱮ  ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱧᱮᱞᱚᱜ-ᱟ ᱢᱮᱱᱛᱮ ᱞᱟ.ᱭ ᱟᱠᱟᱫᱟᱠᱤᱱ ᱾ 
ᱮᱱᱦᱚᱸᱱᱚᱣᱟ ᱞᱚᱷᱭᱚᱬ ᱧᱮᱞᱚᱜ ᱫᱚ ᱯᱨᱟᱭ ᱕ ᱫᱤᱱ ᱵᱟᱝᱠᱷᱟᱱ ᱒᱗ ᱫᱤᱱ ᱦᱚᱸ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱾ 
ᱟᱡᱟᱨ ᱧᱟᱢ ᱟᱠᱟᱫ ᱠᱚ ᱢᱩᱸᱫᱽᱨᱮ ᱛᱤᱱᱟ.ᱜ ᱜᱟᱱ ᱫᱚ ᱨᱮᱸᱜᱮᱡᱽ-ᱚᱨᱮᱡ ᱦᱚᱲᱠᱚ ᱦᱩᱭ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ, ᱡᱟᱦᱟᱸᱭ ᱠᱚᱫᱚ ᱦᱟᱥᱛᱟᱞ ᱨᱮ ᱯᱚᱡᱤᱴᱤᱵᱽ ᱵᱟᱝ ᱧᱟᱢ ᱞᱮᱱᱠᱷᱟᱱ ᱨᱩᱣᱟ.ᱲ ᱠᱟᱠᱚᱣᱟᱠᱚ ᱾ 
ᱚᱱᱟᱛᱮ ᱠᱷᱚᱸᱫᱽᱨᱚᱸᱫᱤᱭᱟ. ᱠᱚ ᱟᱡᱟᱨ ᱧᱟᱢ ᱟᱠᱟᱫ ᱦᱚᱲ ᱴᱷᱮᱱ ᱠᱷᱚᱱ ᱯᱷᱟᱨᱟᱠ ᱧᱚᱜ ᱨᱮ ᱛᱟᱦᱮᱸᱱ ᱞᱟ.ᱜᱤᱱ ᱢᱮᱱ ᱮᱫᱟ ᱠᱚ ᱟᱨ ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱴᱮᱠᱟᱣ ᱫᱟᱨᱟᱢ ᱞᱟ.ᱜᱤᱱ ᱩᱱᱨᱩ ᱩᱳᱜᱤ ᱠᱚ ᱞᱮᱛᱟᱲ ᱱᱚᱡᱚᱨ ᱨᱮ ᱫᱚᱦᱚ ᱥᱟᱶ ᱛᱤᱠᱪᱷᱟ ᱦᱚᱸ ᱞᱟ.ᱠᱛᱤᱭᱟ. ᱾

ᱚᱡᱮ (Cause)
ᱢᱤᱫ ᱴᱷᱮᱫ ᱠᱷᱚᱱ ᱩᱪᱟᱹᱲ
ᱪᱮᱫ ᱞᱮᱠᱟᱨᱮ ᱱᱚᱣᱟ ᱩᱪᱟᱹᱲᱚᱜ ᱠᱟᱱᱟ ᱚᱱᱟ ᱨᱮᱱᱟᱜ ᱴᱷᱟᱹᱣᱠᱟᱹ ᱠᱟᱛᱷᱟ ᱫᱚ ᱱᱤᱛ ᱫᱷᱟᱹᱵᱤᱡ ᱦᱚᱸ ᱯᱟᱲᱦᱟᱣ ᱪᱟᱹᱞᱩ ᱟᱠᱟᱱᱟ ᱾
ᱣᱟᱨᱞᱰ ᱦᱮᱞᱛᱷ ᱳᱨᱜᱟᱱᱟᱭᱦᱮᱥᱚᱱ ᱟᱨ ᱫᱚ ᱭᱩᱱᱟᱭᱴᱮᱰ ᱥᱴᱮᱴᱥ ᱯᱷᱚᱨ ᱰᱤᱡᱤᱡ ᱠᱳᱱᱴᱨᱳᱞᱟ ᱞᱟᱹᱭ ᱞᱮᱠᱟᱛᱮ ᱢᱩᱲ ᱨᱩᱯ ᱛᱮ ᱠᱷᱩᱜ ᱟᱨ ᱥᱟᱦᱮᱫ ᱛᱩᱞᱩᱡ ᱤᱸᱞᱤᱥ ᱛᱮ :en:respiratory droplets ᱨᱮᱥᱯᱤᱨᱮᱴᱳᱨᱤ ᱰᱨᱚᱯᱞᱮᱴ ᱡᱟᱦᱟᱸ ᱠᱚ ᱢᱮᱛᱟᱜ ᱠᱟᱱᱟ ᱚᱱᱟ ᱫᱟᱨᱟᱭ ᱛᱮ ᱱᱚᱣᱟ ᱢᱤᱫ ᱦᱚᱲ ᱴᱷᱮᱫ ᱠᱷᱚᱱ ᱟᱨ ᱢᱤᱫ ᱦᱚᱲ ᱴᱷᱮᱫ ᱩᱪᱟᱹᱲᱚᱜᱼᱟ ᱾  ᱢᱮᱱ ᱟᱠᱚ ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱠᱷᱩᱜ ᱟᱹᱪᱷᱤᱢ ᱚᱠᱛᱚ ᱦᱚᱲ ᱥᱩᱨ ᱥᱩᱯᱩᱨ ᱠᱚ ᱛᱟᱦᱮᱸ ᱞᱮᱱ ᱠᱷᱟᱱ ᱩᱪᱟᱹᱲᱚᱜᱼᱟ ᱾  ᱥᱩᱨ ᱥᱩᱯᱩᱨ ᱢᱮᱱ ᱞᱮᱠᱷᱟᱱ ᱫᱚ ᱑ ᱠᱷᱚᱱ ᱒ ᱢᱤᱴᱚᱨ (᱓-᱖ ᱯᱷᱩᱴ) ᱵᱚᱱ ᱢᱮᱱ ᱮᱫᱟ ᱚᱱᱟ ᱠᱷᱟᱹᱛᱤᱨ ᱡᱟᱦᱟᱸᱭ ᱦᱚᱲ ᱠᱚ ᱠᱚ ᱨᱩᱣᱟᱹᱜ ᱠᱟᱱᱟ ᱩᱱᱠᱩ ᱴᱷᱮᱫ ᱠᱷᱚᱱ ᱑ ᱢᱤᱴᱚᱨ ᱟᱨ ᱵᱟᱝ ᱓ ᱯᱷᱩᱴ ᱥᱟᱦᱟᱨᱮ ᱛᱟᱦᱮᱱ ᱞᱟᱹᱠᱛᱤ ᱠᱟᱱᱟ ᱾ ᱡᱟᱦᱟᱸᱭᱟᱜ ᱦᱚᱲᱢᱚ ᱨᱮ COVID-19 ᱛᱟᱦᱮᱱᱟ ᱟᱨ ᱩᱱᱤ ᱥᱟᱦᱮᱫᱟᱭ ᱟᱨ ᱵᱟᱝ ᱠᱷᱩᱜᱼᱟᱭ  ᱩᱱᱡᱚᱦᱚᱜ ᱚᱱᱟ ᱰᱨᱚᱯᱞᱮᱴ ᱩᱱᱡᱚᱦᱚᱜ ᱥᱤᱨᱡᱟᱹᱣ ᱜᱮᱭᱟ ᱾ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱛᱮ ᱵᱟᱹᱲᱤᱡ ᱟᱠᱟᱱ ᱴᱷᱟᱶ ᱡᱚᱠᱷᱚᱱ ᱢᱤᱫ ᱦᱚᱲ ᱮ ᱡᱚᱴᱮᱫ ᱮᱫᱟ ᱟᱨ ᱚᱱᱟ ᱛᱟᱭᱚᱢ ᱟᱡ ᱟᱡᱟᱜ ᱢᱮᱫ-ᱦᱟᱣ ᱮ ᱡᱚᱴᱮᱫ ᱮᱫᱟ ᱮᱱ ᱨᱮᱦᱚᱸ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱯᱟᱥᱱᱟᱣ ᱜᱮᱭᱟ ᱾ ᱢᱤᱫ ᱦᱚᱲ ᱥᱩᱨ ᱨᱮᱱᱟᱜ ᱡᱟᱦᱟᱱ ᱡᱤᱱᱤᱥ ᱨᱮ ᱟᱨ ᱵᱟᱝ ᱡᱟᱦᱟᱸ ᱴᱷᱟᱶ ᱨᱮ ᱜᱮ ᱱᱚᱣᱟ ᱰᱨᱚᱯᱞᱮᱴ ᱧᱩᱨ ᱞᱮᱱ ᱠᱷᱟᱱ ᱟᱨ ᱚᱱᱟ ᱴᱷᱟᱶ ᱟᱨ ᱵᱟᱝ ᱡᱤᱱᱤᱥ  ᱡᱟᱦᱟᱸᱭ ᱦᱚᱲ ᱜᱮ ᱡᱚᱴᱮᱫᱟᱭ, ᱟᱨ ᱩᱱᱤ ᱦᱚᱲ ᱟᱡᱟᱜ ᱢᱮᱫ ᱢᱩ ᱟᱨ ᱵᱟᱝ ᱢᱚᱪᱟᱭ ᱡᱚᱴᱮᱫ ᱨᱮ ᱦᱚᱸ COVID-19 ᱯᱟᱥᱱᱟᱣ ᱜᱮᱭᱟ ᱾ ᱢᱮᱫ ᱦᱟᱣ ᱥᱮᱫ ᱛᱮ ᱱᱚᱣᱟ ᱩᱪᱟᱹᱲᱚᱜ ᱜᱮᱭᱟᱱ ᱤᱠᱷᱟᱹ ᱨᱤᱥᱠ ᱫᱚ ᱟᱹᱰᱤ ᱠᱚᱢ ᱜᱮᱭᱟ ᱾
ᱡᱟᱦᱟᱸᱛᱤᱨᱮ ᱱᱚᱣᱟ ᱦᱚᱲᱴᱷᱮᱫ ᱞᱚᱠᱷᱭᱚᱬ ᱜᱮ ᱧᱮᱞᱚᱜᱼᱟ ᱩᱱ ᱡᱚᱦᱚᱜ ᱜᱮ ᱵᱟᱹᱲᱛᱤ ᱵᱤᱥ-ᱟᱱᱟ, ᱤᱠᱷᱟᱱ ᱞᱚᱠᱷᱭᱚᱬ ᱧᱮᱞ ᱧᱟᱢᱚᱜ ᱞᱟᱦᱟ ᱨᱮᱦᱚᱸ ᱩᱪᱟᱹᱲᱚᱜ ᱜᱮᱭᱟ, ᱩᱱ ᱡᱚᱦᱚᱜ ᱱᱚᱣᱟ ᱨᱮᱱᱟᱜ ᱵᱤᱯᱚᱫᱽ ᱫᱚ ᱠᱚᱢ ᱜᱮᱭᱟ ᱾ ᱞᱟᱹᱭ ᱮᱫᱟᱭ ᱚᱠᱟ ᱚᱠᱟ ᱴᱷᱟᱶ ᱟᱨ ᱜᱩᱴ ᱠᱚᱨᱮ ᱫᱚ ᱟᱞᱜᱟ ᱛᱮ ᱟᱨ ᱟᱹᱰᱤ ᱠᱮᱴᱮᱡ ᱛᱮ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱯᱟᱥᱱᱟᱣ ᱠᱟᱱᱟ ᱾
ᱭᱩᱨᱳᱯᱤᱭᱚᱱ ᱥᱮᱱᱴᱚᱨ ᱯᱷᱚᱨ ᱰᱤᱡᱤᱡ ᱯᱨᱤᱵᱷᱮᱱᱥᱚᱱ ᱮᱱᱰ ᱠᱚᱱᱴᱨᱳᱞ ᱢᱮᱱᱟᱭ ᱱᱚᱣᱟ ᱰᱨᱚᱯᱞᱮᱴ ᱠᱷᱟᱹᱛᱤᱨ ᱱᱟᱣᱟ ᱟᱡᱟᱨ ᱩᱪᱟᱹᱲᱚᱜ ᱠᱟᱱᱟ ᱤᱠᱷᱟᱹᱱ ᱛᱮᱦᱮᱧ ᱒᱓ ᱢᱟᱨᱪ ᱒᱐᱒᱐ ᱫᱷᱟᱹᱵᱤᱡᱽ ᱢᱚᱦᱟᱢᱟᱹᱨᱤ ᱟᱡᱟᱨ ᱨᱮᱱᱟᱜ ᱜᱮᱭᱟᱱ ᱨᱮᱱᱟᱜ ᱴᱷᱟᱹᱣᱠᱟ ᱠᱷᱚᱵᱚᱨ ᱫᱚ ᱵᱟᱹᱱᱩᱜ ᱟᱹᱱᱤᱡ ᱡᱮ ᱛᱤᱱᱟᱹᱜ ᱞᱟᱜᱮ ᱟᱨ ᱛᱤᱱᱟᱹᱜ ᱡᱤᱣᱤᱫ ᱛᱮ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱢᱤᱫ ᱴᱷᱮᱫ ᱠᱷᱳᱱ ᱟᱨ ᱢᱤᱫ ᱦᱚᱲ ᱴᱷᱮᱫ ᱩᱪᱟᱹᱲᱚᱜᱼᱟ ᱾ ᱮᱴᱟᱜ ᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥᱠᱚ ᱥᱟᱶ SARS-CoV-2 ᱵᱷᱟᱭᱨᱚᱥ  ᱦᱚᱭ ᱨᱮ ᱟᱨ ᱵᱟᱝ ᱮᱴᱟᱜ ᱚᱛ ᱨᱮ ᱛᱤᱱᱟᱹᱜ ᱠᱮᱴᱮᱡᱼᱟ ᱚᱱᱟ ᱛᱩᱞᱟᱹ ᱡᱚᱠᱷᱟ ᱜᱟᱱᱚᱜ ᱜᱮᱭᱟ ᱾ https://www.annualreviews.org/doi/pdf/10.1146/annurev-virology-012420-022445 Seasonality of Respiratory Viral Infections | M. Moriyama | 15 March 2020 | 40–60% relative humidity at room temperature ᱢᱤᱫ ᱯᱚᱲᱦᱚᱱ ᱮ ᱞᱟᱹᱭᱟ SARS-CoV-2 (COVID-19) ᱡᱚᱠᱷᱚᱱ ᱰᱨᱚᱯᱞᱮᱴ ᱛᱩᱞᱩᱡ ᱮ ᱜᱚᱜ ᱦᱚᱪᱚ ᱟ ᱟᱨ ᱡᱚᱠᱷᱚᱱ ᱠᱷᱩᱜ ᱟᱹᱪᱷᱤᱢ ᱡᱚᱦᱚᱜ ᱮ ᱟᱲᱟᱜ ᱮᱭᱟ ᱩᱱᱡᱚᱦᱚᱜ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱟᱨ ᱢᱤᱫ ᱦᱚᱲ ᱴᱷᱮᱫ ᱩᱪᱟᱹᱲᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱡᱤᱣᱤᱫ ᱜᱮ ᱛᱟᱦᱮᱱᱠᱟᱱᱟᱭ, ᱦᱚᱭ ᱨᱮ ᱯᱮ ᱜᱷᱟᱱᱴᱟ ᱜᱟᱱ ᱡᱤᱣᱤᱫ ᱛᱟᱦᱮᱱ ᱠᱟᱱᱟ ᱾ ᱟᱠᱚ SARS-CoV-2 ᱯᱞᱟᱥᱴᱤᱠ ᱥᱴᱤᱞ ᱠᱚᱯᱚᱨ ᱟᱨ ᱠᱟᱨᱰ ᱵᱳᱨᱰ ᱪᱮᱛᱟᱱ ᱨᱮᱠᱚ ᱵᱤᱰᱟᱹᱣ ᱞᱮᱫᱼᱟ, ᱚᱱᱰᱮ ᱠᱚ ᱧᱮᱞ ᱠᱮᱫᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱩᱪᱟᱹᱲᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱯᱞᱟᱥᱴᱤᱠ ᱟᱨ ᱥᱴᱤᱞ ᱨᱮ ᱯᱮ ᱢᱟᱦᱟᱸ ᱠᱟᱨᱰᱽ ᱵᱳᱨᱰ ᱨᱮ ᱢᱤᱫ ᱫᱤᱱ ᱟᱨ ᱠᱚᱯᱚᱨ ᱨᱮ ᱯᱩᱱ ᱜᱷᱟᱱᱴᱟ ᱛᱟᱦᱮᱱᱟ ᱾van Doremalen, Neeltje; Bushmaker; Trenton; Morris, Dylan H.; Holbrook, Myndi G.; Gamble, Amandine; Tamin, Azaibi; Harcourt, Jennifer L., Thornburg, Natalie J. Gerber, Susan I., Lloyd-Smith, James O., de Wit, Emmie, Munster, Vincent J. (17 March 2020)."Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1". The New England Journal of Medicine. Retrieved 20 March 2020.National Institute of Allergy and Infectious Diseases.(17 March 2020)."New coronavirus stable for hours on surfaces: SARS-CoV-2 stability similar to original SARS virus". National Institutes of Health. Retrieved 20 March 2020.Howard, Jacqueline, and Hanna, Jason. (18 March 2020)."The new coronavirus can last on surfaces for up to three days, study says". CNN. Retrieved 20 March 2020. ᱤᱠᱷᱟᱹᱱ ᱚᱠᱛᱚ ᱵᱷᱟᱭᱨᱚᱥ ᱮ ᱛᱟᱦᱮᱱᱟ ᱚᱛᱨᱮ ᱛᱤᱱᱟᱜ ᱞᱚᱞᱚ (Temperature) ᱟᱨ ᱟᱞᱟᱣᱮᱫᱽ (Humidity) ᱛᱟᱦᱮᱱᱟ ᱚᱱᱟ ᱦᱤᱥᱟᱹᱵ ᱛᱮ ᱵᱚᱫᱚᱞᱚᱜᱼᱟ ᱾ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱟᱵᱚ ᱥᱟᱦᱮᱫ ᱵᱚᱱ ᱤᱫᱤᱭᱮᱫ ᱡᱩᱫᱤ ᱪᱚ ᱦᱚᱭ ᱨᱮᱦᱚᱸ ᱛᱤᱱᱟᱹᱜ ᱯᱮ ᱜᱷᱟᱱᱴᱟ ᱫᱚ ᱡᱤᱭᱟᱹᱲ ᱜᱮ ᱛᱟᱦᱮᱱ ᱠᱟᱱᱟ ᱾
ᱡᱟᱦᱟᱸ ᱴᱷᱟᱶ SARS-CoV-2 ᱛᱮ ᱵᱤᱥ ᱟᱠᱟᱱᱟ ᱟᱨ ᱵᱟᱝ ᱵᱟᱹᱲᱤᱡ ᱟᱠᱟᱱᱟ ᱚᱱᱟ ᱛᱤᱱᱟᱹᱜ ᱜᱟᱱ ᱠᱟᱹᱢᱤ ᱦᱚᱨᱟ ᱛᱮ ᱱᱟᱥᱮᱱᱟᱜ ᱯᱷᱟᱨᱪᱟ ᱜᱟᱱᱚᱜ ᱜᱮᱭᱟ ᱡᱮᱢᱚᱱ (ᱢᱤᱫ ᱢᱤᱱᱤᱴ ᱵᱤᱱᱟᱹ ᱫᱟᱜᱼᱟ ᱥᱴᱤᱞ ᱛᱮ ᱥᱚᱫᱚᱨ ᱮᱞᱠᱷᱟᱱ), ᱥᱟᱶ 62–71% ᱤᱛᱷᱟᱱᱚᱞ, 50-100% ᱟᱭᱥᱳ-ᱯᱨᱳᱯᱟᱱᱳᱞ, 0.1% ᱥᱳᱰᱤᱭᱚᱢ ᱦᱟᱭᱯᱳ-ᱠᱞᱳᱨᱟᱭᱤᱴ, 0.᱕% ᱦᱟᱭᱰᱨᱳᱡᱮᱱ ᱯᱮᱨᱳᱠᱥᱟᱭᱤᱰ ᱟᱨ 0.2–7.5% ᱯᱨᱳᱵᱷᱤᱰᱳᱱ-ᱟᱭᱳᱰᱤᱱ; ᱵᱮᱱᱡᱟᱞᱠᱳᱱᱤᱭᱚᱢ ᱟᱨ ᱠᱞᱳᱨᱮᱠᱥᱰᱟᱟᱭᱤᱱ ᱜᱞᱩᱠᱳᱱᱮᱴ ᱫᱚ ᱩᱱᱟᱹᱜ ᱵᱟᱭ ᱠᱟᱹᱢᱤᱭᱟ ᱾

ᱡᱤᱣ ᱯᱤᱞᱤᱧ ᱥᱟᱬᱮᱥ (Virology)
ᱥᱟᱦᱮᱫᱨᱮ ᱟᱹᱰᱤ ᱥᱚᱠᱛᱚ ᱟᱨ ᱥᱟᱹᱨᱫᱤ ᱟᱹᱰᱤᱜᱟᱱ ᱟᱡᱟᱨ ᱞᱚᱠᱥᱚᱬ coronavirus 2 (SARS-CoV-2)ᱱᱳᱵᱷᱮᱞ  ᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱠᱟᱱᱟᱭ ᱡᱟᱦᱟᱸ ᱫᱚ ᱪᱤᱱ ᱨᱮᱱᱟᱜ ᱩᱦᱟᱱ ᱨᱮ ᱯᱩᱭᱞᱩ ᱫᱷᱟᱣ ᱯᱮ ᱦᱚᱲ ᱥᱮᱦᱮᱫ ᱟᱡᱟᱨ ᱨᱩᱜᱤ ᱴᱷᱮᱫ ᱱᱤᱢᱚᱱᱤᱭᱟ ᱟᱡᱟᱨ ᱥᱟᱶ ᱞᱮᱱ ᱛᱟᱦᱮᱸᱫ ᱚᱱᱠᱩ ᱴᱷᱮᱫ ᱠᱷᱚᱱ ᱠᱳᱨᱳᱱᱟ ᱨᱩᱜᱤ ᱠᱚ ᱮᱠᱞᱟ ᱞᱮᱫᱮᱭᱟ ᱾ᱱᱳᱵᱷᱮᱞ SARS-CoV-2 ᱵᱷᱟᱭᱨᱚᱥ ᱨᱮᱱᱟᱜ ᱜᱩᱬ ᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱞᱮᱠᱟ ᱯᱨᱚᱠᱨᱩᱛᱤ ᱨᱮᱜᱮ ᱥᱤᱨᱡᱟᱹᱣᱟ ᱾
ᱢᱩᱲ SARS-CoV ᱥᱟᱶ SARS-CoV-2 ᱟᱹᱰᱤ ᱢᱤᱫ ᱜᱮᱭᱟ ᱟᱨ ᱥᱩᱨ ᱥᱩᱯᱩᱨ ᱜᱮᱭᱟ ᱾ ᱱᱚᱣᱟ ᱠᱚ ᱢᱮᱱᱟ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱨᱮᱱᱟᱜ ᱢᱩᱲᱩᱛ  ᱫᱚ ᱡᱩᱱᱚᱴᱤᱠ ᱠᱟᱱᱟ ᱾ ᱡᱮᱱᱮᱴᱤᱠ ᱠᱚᱸᱫᱨᱚᱫ ᱵᱤᱪᱟᱹᱨᱤᱭᱟ ᱠᱚ ᱥᱚᱫᱚᱨ ᱟᱠᱟᱫᱟ ᱡᱤᱱ ᱞᱮᱠᱟᱛᱮ ᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱫᱚ  :en:Betacoronavirus:ᱵᱤᱴᱟᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ '''ᱟᱨ ᱥᱚᱵ ᱡᱮᱱᱚᱥ ᱥᱟᱨᱵᱮᱠᱳᱵᱷᱤᱨᱚᱥ -(lineage B) ᱟᱨ  ᱵᱟᱨᱫᱩᱲᱩᱡᱽ ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱥᱟᱶ ᱛᱚᱯᱚᱞ ᱢᱮᱱᱟᱜ-ᱟ ᱾ ᱱᱚᱣᱟ ᱨᱮᱱᱟᱜ ᱯᱩᱨᱟ.  ᱡᱮᱱᱳᱢ ᱙᱖% ᱵᱟᱨᱫᱩᱲᱩᱡᱽ ᱠᱳᱨᱳᱱᱟᱵᱷᱟᱭᱨᱚᱥ ᱥᱟᱢᱯᱩᱞ (BatCov RaTG13) ᱥᱟᱶ ᱜᱩᱬ ᱨᱮ ᱢᱮᱥᱟᱜ ᱠᱟᱱᱟ ᱾ ᱟᱨ ᱦᱚᱸ ᱯᱷᱮᱵᱨᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱪᱤᱱ ᱨᱤᱱ ᱠᱚᱸᱫᱽᱨᱚᱸᱫᱤᱭᱟᱹ ᱠᱚ ᱵᱟᱰᱟᱭ ᱧᱟᱢ ᱠᱮᱫᱟ, ᱢᱤᱫᱴᱟᱝ ᱟᱢᱤᱱᱳ ᱮᱥᱤᱰᱽ ᱵᱟᱫᱽ ᱠᱟᱛᱮᱫ :en:pangolins:ᱯᱟᱱᱜᱳᱞᱤᱱᱥ ᱟᱨ ᱢᱟᱹᱱᱢᱤᱭᱟᱜ ᱨᱮᱠᱚ ᱧᱮ ᱠᱮᱫᱟᱠᱚ ᱙᱒% ᱜᱮᱱᱮᱴᱤᱞ ᱡᱤᱱᱤᱥ ᱯᱟᱱᱜᱳᱞᱤᱱ ᱠᱳᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱟᱨ SARS-CoV-2 ᱢᱤᱫ ᱜᱮᱭᱟ ᱾ ᱱᱚᱰᱮ ᱠᱷᱚᱱ ᱵᱟᱰᱟᱭᱚᱜ ᱠᱟᱱᱟ ᱯᱟᱱᱜᱳᱞᱤᱱᱥ ᱡᱮ ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱚᱥ  ᱤᱱᱴᱮᱨᱢᱤᱰᱤᱭᱮᱴ ᱦᱳᱥᱴ ᱫᱚᱭ ᱵᱟᱝ ᱠᱟᱱᱟ᱾

Diagnosis
ᱵᱟᱭᱨᱟᱞ ᱵᱤᱰᱟᱹᱣ (Viral testing)
ᱜᱩᱱᱟᱹᱱ (Imaging)

ᱫᱟᱯᱟᱨᱟᱢ (Prevention)
ᱟᱡᱟᱨ ᱨᱮᱭᱟᱜ ᱯᱟᱯᱟᱥᱱᱟᱣ ᱫᱟᱯᱟᱨᱟᱢ ᱞᱟᱹᱜᱤᱫ ᱨᱟᱹᱲᱦᱟᱹᱭ ᱟᱹᱨᱤ ᱞᱮᱠᱟ ᱛᱮ ᱟᱯᱟᱱ ᱯᱟᱨᱪᱦᱟ ᱯᱟᱹᱨᱪᱷᱤ ᱛᱟᱦᱮᱱ ᱦᱚᱸ ᱞᱟᱹᱠᱛᱤ ᱠᱟᱱᱟ, ᱛᱤ ᱠᱤᱱ ᱟᱵᱚᱜᱽ ᱯᱟᱹᱨᱪᱷᱟᱹ, ᱟᱯᱱᱟᱨ ᱟᱜ ᱵᱤᱥ ᱯᱟᱹᱨᱪᱷᱟᱹ ᱛᱤ ᱛᱮ ᱢᱮᱫ ᱠᱤᱱ, ᱢᱩᱸ, ᱢᱚᱪᱟ ᱮᱢᱟᱱ ᱡᱚᱴᱮᱫ ᱠᱷᱚᱱ ᱥᱟᱦᱟᱲ ᱨᱮ ᱛᱟᱦᱮᱱ, ᱠᱷᱩᱜ ᱥᱮ ᱟᱹᱪᱷᱤᱢ ᱚᱠᱛᱮ ᱛᱤᱥᱩ ᱠᱟᱜᱚᱡᱽ ᱵᱚᱱ ᱵᱮᱵᱷᱟᱨ ᱢᱟ ᱟᱨ ᱚᱱᱟ ᱴᱤᱥᱩ ᱠᱟᱜᱚᱡᱽ ᱥᱤᱫᱷᱟᱹ ᱰᱟᱥᱵᱤᱱ ᱨᱮᱵᱚ ᱜᱤᱰᱤ ᱠᱟᱜ-ᱟ |ᱚᱠᱚᱭ ᱠᱚ ᱱᱤᱛ ᱦᱟᱹᱵᱤᱡ ᱛᱮ ᱡᱟᱹᱵᱽᱲᱤ ᱫᱟᱲᱮᱭᱟᱜ-ᱟ ᱠᱚ, ᱩᱱᱠᱩ ᱫᱚ ᱥᱟᱨᱡᱤᱠᱮᱞ ᱢᱟᱥᱠ (ᱢᱚᱪᱟ ᱴᱚᱯᱟᱨᱟᱜ) ᱦᱚᱨᱚᱜ ᱠᱚ ᱱᱮᱦᱚᱨ ᱚᱪᱚᱜ ᱠᱟᱱᱟ᱾ ᱟᱡᱟᱨ ᱡᱟᱹᱵᱽᱲᱤ ᱠᱷᱚᱱ ᱵᱟᱧᱪᱟᱣᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱥᱟᱶᱛᱟᱨᱤ ᱥᱟᱯᱟᱹᱝᱜᱤᱧ ᱦᱚᱸ ᱟᱹᱰᱤ ᱞᱟᱹᱠᱛᱤ ᱢᱮᱱᱟᱜ ᱟᱠᱟᱫᱟ|

ᱟᱭᱢᱟ ᱫᱤᱥᱚᱢ ᱨᱮᱱ ᱥᱚᱨᱠᱟᱨ ᱜᱮ ᱮᱴᱟᱜ ᱫᱤᱥᱚᱢ ᱥᱮ ᱮᱴᱟᱜ ᱴᱚᱴᱷᱟ ᱠᱚ ᱛᱮ ᱵᱤᱱ ᱡᱚᱥ ᱫᱟᱲᱟᱱ ᱫᱚ ᱠᱚ ᱢᱟᱱᱟ ᱟᱠᱟᱫᱟ ᱥᱮ ᱵᱟᱝ ᱫᱟᱲᱟᱱ ᱨᱮᱭᱟᱜ ᱥᱚᱞᱦᱟ ᱠᱚ ᱮᱢ ᱟᱠᱟᱱᱟ |ᱪᱮᱫᱟᱜ ᱥᱮ ᱱᱩᱠᱩ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱫᱚ ᱫᱩᱱᱤᱭᱟᱹ ᱨᱮᱭᱟᱜ ᱢᱟᱨᱟᱝ ᱦᱤᱸᱥ ᱨᱮ ᱠᱚ ᱯᱟᱥᱱᱟᱣ ᱮᱱᱟ, ᱢᱤᱢᱤᱫ ᱠᱚᱪᱟ ᱠᱚᱨᱮ ᱠᱚ ᱛᱤᱭᱚᱜ ᱠᱮᱫᱟ᱾ ᱱᱚᱣᱟ ᱠᱟᱴᱷᱟ ᱨᱮᱭᱟᱜ ᱢᱮᱱᱮᱛ ᱫᱚ ᱱᱚᱣᱟ ᱦᱩᱭᱩᱜ ᱠᱟᱱᱟ ᱡᱮ, ᱱᱩᱠᱩ ᱵᱷᱟᱭᱨᱟᱥ ᱫᱚ ᱱᱚᱝᱠᱟᱱ ᱡᱟᱩᱜᱟ ᱠᱚ ᱨᱮ ᱷᱳᱸ ᱠᱚ ᱯᱟᱥᱱᱟᱣᱮᱱᱟ ᱚᱠᱟ ᱡᱟᱭᱜᱟ ᱨᱮᱱ ᱷᱚᱲ ᱫᱚ ᱮᱴᱟᱜ ᱡᱟᱭᱜᱟ ᱵᱟᱠᱚ ᱫᱟᱬᱟ ᱵᱟᱲᱟ ᱟᱠᱟᱫ᱾

ᱛᱤ ᱟᱵᱚᱜᱚᱜ
ᱟᱡᱟᱨ ᱵᱟᱝ ᱯᱟᱥᱱᱟᱣᱚᱜ ᱞᱟᱹᱜᱤᱫ ᱛᱤ ᱱᱟᱭ ᱱᱟᱯᱟᱭ ᱛᱮ ᱟᱵᱚᱜ ᱥᱟᱯᱷᱟ ᱨᱮᱭᱟᱜ ᱥᱚᱞᱦᱟ ᱠᱚ ᱮᱢᱚᱜᱚᱜ ᱠᱟᱱᱟ᱾ CDC ᱟᱜ ᱥᱚᱞᱦᱟ ᱞᱮᱠᱟ ᱛᱮ ᱡᱮᱢᱚᱱ ᱡᱚᱛᱚ ᱠᱚᱢ ᱨᱮ ᱦᱚᱸ ᱒᱐ ᱴᱤᱯᱤᱡ ᱦᱟᱹᱵᱤᱡ ᱛᱤ ᱥᱟᱹᱵᱩᱱ ᱛᱮᱠᱚ ᱥᱟᱥᱟᱣᱚᱜ ᱟᱨ ᱫᱟᱜ ᱛᱮᱠᱚ ᱟᱹᱨᱩᱵ ᱥᱟᱯᱷᱟᱜ ᱢᱟ, ᱟᱥᱚᱠᱟᱭ ᱛᱮ ᱨᱟᱪᱟ ᱛᱮ ᱥᱮ ᱴᱟᱹᱱᱰᱤ ᱛᱮ ᱠᱷᱚᱱ ᱨᱩᱣᱟᱹᱲ ᱠᱟᱛᱮ ᱥᱮ ᱛᱤᱱ ᱚᱠᱛᱮ ᱨᱮ ᱛᱤ ᱢᱟᱹᱭᱞᱟᱹ ᱜᱮ ᱧᱮᱞ ᱩᱨᱩᱢᱚᱜ-ᱟ᱾ ᱡᱚᱢ ᱞᱟᱦᱟ ᱨᱮ ᱟᱨ ᱱᱩ ᱦᱚᱴᱚᱨ, ᱠᱷᱩᱜ ᱟᱨ ᱟᱹᱪᱷᱤᱢ ᱛᱟᱭᱚᱢ ᱛᱮ᱾

ᱥᱟᱸᱦᱮᱸᱫ ᱮᱢᱟᱱ ᱠᱚᱨᱮ ᱯᱷᱟᱹᱨᱪᱟ ᱯᱷᱟᱹᱨᱪᱤ (Respiratory hygiene)

ᱫᱤᱥᱣᱟᱹ ᱥᱟᱹᱯᱟᱹᱜᱤᱧ (Social distancing)

ᱱᱟᱜᱟᱢ
ᱨᱩᱜᱤ ᱥᱩᱱ ᱟᱹᱲᱟᱹ ᱢᱤᱫ ᱨᱩᱣᱟᱹ ᱨᱮᱱᱟᱜ ᱯᱩᱭᱞᱩ ᱫᱷᱟᱣ ᱢᱚᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱜᱟᱞᱚᱪ ᱞᱟᱹᱜᱤᱫ ᱛᱮ ᱠᱟᱹᱢᱤ ᱦᱩᱭ ᱟᱠᱟᱱᱟ᱾ ᱟᱭᱢᱟ ᱜᱟᱱ ᱥᱤᱫᱽᱫᱚᱱᱛᱚ ᱦᱩᱭ ᱤᱫᱤᱜ ᱠᱟᱱᱟ ᱟᱨ ᱨᱩᱜᱤ ᱥᱩᱱ ᱢᱚᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱩᱛᱱᱟᱹᱣ ᱚᱠᱟ ᱠᱷᱚᱱ ᱦᱮᱡ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ᱾ ᱩᱯᱚᱱᱭᱟᱥ ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱱᱟᱜ ᱢᱟᱲᱟᱝ ᱵᱟᱰᱟᱭ ᱢᱚᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱠᱷᱚᱡᱟᱣ ᱪᱟᱭᱱᱟ ᱨᱮᱱᱟᱜ ᱦᱩᱵᱮᱭ ᱨᱮᱱᱟᱜ ᱦᱩᱣᱟᱱ ᱨᱮ ᱑ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱒᱐᱑᱙ ᱦᱤᱞᱚᱜ ᱫᱚᱦᱲᱟ ᱥᱮᱱ ᱨᱩᱣᱟᱹᱲ ᱞᱮᱱᱟ᱾ ᱛᱟᱭᱚᱢ ᱛᱮ ᱢᱤᱫ ᱚᱯᱩᱥᱴ ᱨᱟᱱ ᱠᱷᱚᱱ ᱵᱟᱰᱟᱭ ᱧᱟᱢ ᱮᱱᱟ ᱡᱮ ᱮᱦᱚᱵ ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱱᱟᱜ ᱥᱤᱠᱟᱨ ᱨᱮ ᱢᱤᱫ ᱕᱕ ᱥᱮᱨᱢᱟ ᱨᱮᱱ ᱦᱚᱲ ᱮ ᱛᱟᱦᱮᱸᱜ ᱠᱟᱱᱟ ᱡᱟᱦᱟᱸᱭ ᱑᱗ ᱱᱚᱣᱮᱢᱵᱚᱨ ᱒᱐᱑᱙ ᱦᱤᱞᱚᱜ ᱨᱩᱣᱟᱹ ᱥᱟᱵ ᱞᱮᱫᱮᱭᱟᱭ ᱾ ᱫᱚᱥᱟᱨ ᱪᱟᱸᱫᱚ ᱵᱷᱤᱛᱨᱤ ᱛᱮ, ᱦᱩᱵᱮᱭ ᱨᱮ ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱱᱟᱜ ᱢᱚᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱮᱞᱮᱞ ᱵᱟᱹᱭ ᱧᱚᱜ ᱥᱟᱭ ᱨᱮᱱ ᱢᱤᱫ ᱡᱚᱲ ᱵᱟᱲᱦᱟᱣ ᱮᱱᱟ, ᱡᱟᱱᱩᱣᱚᱨᱤ ᱒᱐᱒᱐ ᱨᱮ ᱟᱹᱰᱤ ᱞᱟᱜᱮ ᱛᱮ ᱵᱟᱲᱦᱟᱣ ᱠᱷᱚᱱ ᱢᱟᱲᱟᱝ ᱓᱑ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱒᱐᱑᱙ ᱦᱤᱞᱚᱜ ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱫᱚ ᱵᱟᱝ ᱵᱟᱰᱟᱭ ᱠᱟᱛᱮ ᱱᱤᱢᱚᱱᱤᱭᱟ ᱢᱟᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱠᱟᱨᱚᱱ ᱛᱮ ᱦᱩᱵᱮᱭ ᱯᱨᱟᱸᱛ ᱨᱮᱱᱟᱜ ᱨᱟᱡᱽᱫᱷᱟᱱᱤ ᱣᱩᱦᱟᱱ ᱨᱮ ᱦᱮᱞᱛᱷ ᱰᱮᱯᱟᱨᱴᱢᱮᱸᱛ ᱠᱚ ᱠᱷᱚᱵᱚᱨ ᱟᱫ ᱠᱚ ᱛᱟᱦᱮᱱᱟ ᱾ ᱢᱤᱫ ᱯᱟᱸᱡᱟ ᱞᱮᱠᱟᱛᱮ ᱴᱨᱤᱜᱚᱨ ᱞᱟᱹᱜᱤᱫ ᱱᱚᱶᱟ ᱵᱟᱹᱲᱛᱤ ᱦᱩᱣᱚᱱ ᱥᱚᱦᱚᱨ ᱥᱤᱯᱷᱩᱰ ᱦᱚᱞᱥᱮᱞ ᱦᱟᱴ ᱜᱷᱚᱱ ᱡᱚᱲᱟᱣ ᱛᱟᱦᱮᱸᱜ ᱠᱟᱱᱟ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱡᱤᱣᱮᱫ ᱡᱟᱱᱣᱟ ᱠᱚ ᱟᱠᱨᱤᱝ ᱮᱫ ᱠᱚ ᱛᱟᱦᱮᱱᱟ; ᱱᱚᱝᱠᱟ ᱜᱮ ᱵᱟᱰᱟᱭ ᱧᱟᱢᱚᱜ ᱠᱟᱱᱟ ᱡᱮ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮ ᱢᱤᱫ ᱡᱩᱱᱮᱴᱤᱠ ᱩᱛᱱᱟᱣ ᱢᱮᱱᱟᱜᱼᱟᱥ ᱾ ᱮᱛᱚᱦᱚᱵ ᱪᱚᱨᱚᱱ ᱚᱠᱛᱮ ᱢᱟᱢᱞᱟ ᱨᱮᱱᱟᱜ ᱮᱞᱮᱞ ᱟᱢᱫᱟᱡᱽ ᱛᱮ ᱥᱟᱨᱟ ᱥᱟᱲᱷᱮ ᱮᱭᱟᱭ ᱢᱟᱦᱟᱸ ᱨᱮ ᱵᱟᱨ ᱜᱟᱵᱟᱬ ᱦᱩᱭ ᱟᱠᱟᱱᱟ᱾ ᱩᱥᱟᱹᱨᱟ ᱟᱨ ᱛᱟᱞᱟ ᱡᱟᱱᱩᱣᱚᱨᱤ ᱒᱐᱒᱐ ᱨᱮ, ᱵᱷᱟᱭᱨᱟᱥ ᱟᱭᱢᱟ ᱪᱟᱭᱱᱟ ᱯᱨᱟᱸᱛ ᱨᱮ ᱪᱷᱟᱹᱨᱭᱟᱣ ᱮᱱᱟ ᱾ ᱡᱟᱦᱟᱸ ᱫᱚ ᱱᱟᱶᱟ ᱥᱮᱨᱢᱟ ᱨᱮᱱᱟᱜ ᱵᱚᱞᱚᱱ ᱨᱮ ᱜᱚᱲᱚ ᱦᱩᱭ ᱟᱠᱟᱱᱟ ᱾ ᱣᱩᱦᱟᱱ ᱴᱨᱟᱱᱥᱯᱚᱨᱴ ᱦᱚᱵᱽ ᱟᱨ ᱟᱥᱚᱞ ᱫᱚ ᱨᱮᱞ ᱤᱱᱴᱚᱨᱪᱮᱸᱡᱽ ᱦᱩᱭ ᱥᱟᱶ, ᱟᱨ ᱥᱚᱝᱠᱨᱚᱢᱚᱬ ᱩᱥᱟᱹᱨᱟ ᱛᱮ ᱥᱟᱱᱟᱢ ᱫᱤᱥᱚᱢ ᱨᱮ ᱪᱟᱹᱨᱭᱟᱹᱣ ᱮᱱᱟ ᱾ ᱦᱩᱣᱚᱱ ᱢᱤᱫ ᱜᱟᱹᱲᱤ ᱠᱚ ᱦᱤᱡᱩᱜ ᱥᱮᱱᱚᱜ ᱴᱷᱟᱶ ᱟᱨ ᱟᱥᱚᱞ ᱫᱚ ᱨᱮᱞ ᱤᱱᱴᱚᱨᱪᱮᱱᱡᱽ ᱦᱩᱭ ᱥᱟᱶ ᱟᱨ ᱥᱳᱝᱠᱨᱳᱬᱳᱱ ᱟᱹᱰᱤ ᱞᱚᱜᱚᱱ ᱜᱮ ᱡᱮᱜᱮᱛ ᱫᱤᱥᱚᱢ ᱨᱮ ᱪᱷᱟᱹᱨᱭᱟᱹᱣ ᱮᱱᱟ ᱾ ᱒᱐ ᱡᱟᱱᱩᱣᱚᱨᱤ ᱦᱤᱞᱚᱜ, ᱪᱤᱱ ᱫᱚ ᱢᱤᱫ ᱢᱟᱦᱟᱸ ᱨᱮ ᱟᱢᱫᱟᱡᱽ ᱛᱮ ᱑᱔᱐ ᱴᱟᱜ ᱜᱟᱱ ᱢᱟᱢᱞᱟ ᱨᱮᱡᱤᱥᱴᱚᱨ ᱟᱠᱟᱱᱟ ᱾   thumb|upright=1.6|ᱫᱤᱥᱚᱢ ᱦᱚᱛᱮᱛᱮ ᱢᱤᱫ ᱞᱚᱜᱮᱨᱤᱫᱚᱢ ᱯᱮᱭᱢᱟᱱᱟ ᱨᱮ ᱢᱮᱱᱟᱜ ᱯᱞᱚᱴ ᱢᱚᱢᱞᱟ

 ᱜᱷᱟᱨᱚᱧᱡᱽ ᱨᱮ ᱫᱟᱭᱤᱠ (Domestic responses)  

More than 170 territories have had at least one case.  ᱩᱨᱚᱯ ᱨᱮ ᱢᱟᱦᱟᱢᱟᱨᱤ ᱠᱷᱟᱹᱛᱤᱨ ᱛᱮ ᱥᱮᱝᱜᱮᱱ ᱴᱚᱴᱷᱟ ᱨᱮᱱᱟᱜ ᱟᱭᱢᱟ ᱫᱤᱥᱚᱢ ᱟᱲᱟᱜ ᱟᱣᱟᱡᱽᱫᱟᱦᱤ ᱠᱚ ᱨᱮᱱᱟᱜ ᱢᱟᱱᱟ ᱵᱟᱨᱚᱱ ᱦᱩᱭ ᱟᱠᱟᱱᱟ ᱟᱨ ᱥᱤᱢᱟ ᱨᱮᱱᱟᱜ ᱜᱚᱵᱚᱞ ᱠᱚ ᱛᱷᱟᱯᱚᱱ ᱟᱠᱟᱫᱟ᱾  ᱡᱟᱹᱛᱤᱭᱟᱹᱨᱤ ᱨᱤᱭᱮᱠᱥᱚᱱ ᱨᱮ ᱥᱚᱝᱨᱚᱫᱷ ᱟᱨ ᱠᱚᱨᱯᱷᱭᱩ ᱞᱮᱠᱟᱱ ᱨᱚᱠᱛᱷᱟᱢ ᱨᱮᱱᱟᱜ ᱩᱯᱟᱭ ᱠᱚ ᱥᱮᱞᱮᱫ ᱢᱮᱱᱟᱜᱼᱟ ᱾ 
ᱪᱤᱱ ᱫᱤᱥᱚᱢ
ᱱᱟᱶᱟ ᱵᱷᱟᱭᱨᱟᱥ  ᱨᱮᱱᱟᱜ ᱠᱟᱨᱚᱱ ᱛᱮ ᱨᱩᱣᱟᱹ ᱛᱮ ᱯᱟᱲᱟᱣ ᱟᱠᱟᱱ ᱯᱩᱭᱞᱩ ᱦᱚᱲᱟᱜ ᱵᱟᱰᱟᱭ ᱫᱚ ᱣᱩᱦᱟᱱ ᱥᱚᱦᱚᱨ ᱨᱮ ᱑ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱒᱐᱑᱙ ᱨᱮ ᱵᱟᱰᱟᱭ ᱮᱱᱟ ᱾thumb|"Aerial photography of roads after motor vehicles are banned in central urban areas of Wuhan: few vehicle traces"—Video news from China News Service

ᱮᱛᱚᱢ ᱠᱚᱨᱤᱭᱟ

ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱫᱚ ᱫᱟᱹᱠᱷᱤᱱ ᱠᱚᱨᱤᱭᱟ ᱨᱮ ᱪᱤᱱ ᱠᱷᱚᱱᱟᱜ ᱒᱐ ᱡᱟᱱᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱦᱤᱞᱚᱜ ᱦᱮᱡ ᱮᱱᱟ ᱾ ᱒᱐ ᱯᱷᱮᱵᱽᱨᱩᱣᱟᱨᱤ ᱛᱮ ᱫᱚ ᱱᱚᱰᱮ ᱠᱚᱨᱚᱱᱟ ᱟᱡᱟᱨᱤᱭᱟᱹ ᱟᱰᱤ ᱜᱟᱱ ᱠᱚ ᱵᱟᱹᱲᱛᱤ ᱮᱱᱟ ᱾ 

᱔᱒ ᱡᱷᱚᱬ ᱵᱷᱚᱠᱛᱚ ᱪᱤᱱ ᱨᱮᱭᱟᱜ ᱩᱦᱟᱱ ᱠᱷᱚᱱᱟᱜ ᱫᱟᱭᱜᱩ ᱠᱚ ᱦᱮᱡ ᱞᱮᱱᱟ ᱡᱟᱦᱟᱸᱭ ᱫᱚ ᱱᱚᱶᱟ ᱟᱡᱟᱨ ᱠᱚ ᱟᱹᱜᱩ ᱛᱟᱨᱟ ᱞᱮᱜ-ᱟ ᱢᱮᱱᱛᱮ ᱵᱟᱰᱟᱭᱚᱜ ᱠᱟᱱᱟ ᱾  ᱒᱒ ᱯᱷᱮᱵᱽᱨᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱦᱟᱟᱹᱵᱤᱡ ᱛᱮ ᱙,᱓᱓᱖ ᱵᱷᱚᱠᱛᱚ ᱠᱷᱚᱱᱟᱜ ᱑,᱒᱖᱑ ᱡᱷᱚᱬᱟᱜ ᱫᱚ (᱑᱓ %) ᱞᱚᱪᱷᱱᱟ ᱥᱚᱫᱚᱨ ᱞᱮᱱᱟ ᱾  

ᱫᱟᱹᱠᱷᱤᱱ ᱠᱚᱨᱤᱭᱟ ᱫᱚ ᱒᱓ ᱯᱷᱮᱵᱽᱨᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱦᱤᱞᱚᱜ ᱟᱹᱰᱤ ᱡᱩᱨ ᱥᱚᱱᱛᱚᱨ ᱮ ᱜᱷᱚᱥᱚᱬᱟ ᱠᱮᱜ-ᱟ ᱾  ᱒᱘ ᱯᱷᱮᱵᱽᱨᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱨᱮᱫᱚ ᱱᱚᱰᱮ ᱒,᱐᱐᱐ ᱠᱷᱚᱱᱟᱜ ᱵᱟᱹᱲᱛᱤ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱟᱡᱟᱨ ᱨᱮᱠᱚ ᱵᱟᱲᱟᱣ ᱮᱱᱟ ᱾  ᱒᱙ ᱯᱷᱮᱵᱽᱨᱩᱣᱟᱨᱤ ᱛᱮᱜᱮ ᱠᱚᱵᱷᱤᱰ-᱑᱙ ᱟᱡᱟᱨ ᱨᱮ ᱯᱟᱲᱟᱣ ᱟᱠᱟᱱ ᱦᱚᱲᱟᱜ ᱮᱞ ᱓,᱑᱕᱐ ᱥᱮᱴᱮᱨ ᱮᱱᱟ ᱾  ᱡᱚᱠᱷᱚᱱ ᱱᱚᱰᱮᱱ ᱠᱚ ᱥᱤᱯᱟᱦᱤ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱩᱣᱟᱹᱬᱤ (ᱵᱷᱟᱭᱨᱚᱥ) ᱧᱟᱢ ᱠᱮᱫ ᱠᱚᱣᱟ ᱫᱟᱹᱠᱷᱤᱱ ᱠᱚᱨᱤᱭᱟ ᱥᱚᱨᱠᱟᱨ ᱡᱚᱛᱚ ᱥᱤᱯᱟᱹᱦᱤ ᱮᱠᱞᱟ ᱨᱮ ᱛᱟᱦᱮᱸᱱ ᱞᱟᱹᱜᱤᱫ ᱮ ᱱᱮᱦᱚᱸᱨ ᱠᱮᱫ ᱠᱚᱣᱟ ᱾ ᱩᱰᱟᱹᱵ ᱜᱟᱹᱰᱤ ᱨᱮᱱ ᱠᱟᱹᱢᱤᱭᱟᱹ ᱠᱚᱦᱚᱸ ᱠᱚᱨᱚᱱᱟ ᱵᱷᱟᱭᱨᱚᱥ ᱧᱟᱢ ᱠᱮᱫ ᱠᱚ ᱠᱷᱟᱱ ᱟᱹᱰᱤ ᱜᱟᱱ ᱩᱫᱟᱹᱜ ᱜᱟᱹᱰᱤ ᱵᱟᱹᱛᱤᱞ ᱮᱱᱟ ᱾ 

ᱤᱨᱟᱱ
ᱤᱴᱟᱞᱤ
ᱥᱯᱮᱭᱱ
ᱤᱝᱜᱽᱞᱮᱱᱰ
ᱟᱢᱮᱨᱤᱠᱟ

ᱡᱮᱜᱮᱫ ᱡᱟᱠᱟᱛ ᱫᱟᱭᱤᱠ
ᱮᱞᱟᱝ ᱚᱨᱥᱚᱝ
ᱨᱟᱡᱟᱨᱤ
ᱥᱮᱪᱮᱫ
ᱥᱟᱶᱛᱟ-ᱠᱟᱹᱣᱰᱤ ᱟᱹᱨᱤ
ᱦᱚᱭ-ᱦᱤᱥᱤᱫ
ᱞᱟᱭ-ᱞᱞᱟᱠᱪᱟᱨ
 ᱱᱚᱸᱰᱮ ᱦᱚᱸ ᱧᱮᱞᱢᱮ 
 ᱠᱚᱨᱳᱱᱟ ᱵᱷᱟᱭᱨᱟᱥ
ᱵᱟᱦᱨᱮ ᱡᱚᱱᱚᱲ

ᱥᱟᱹᱠᱷᱭᱟᱹᱛ

ᱛᱷᱚᱠ:ᱫᱳᱹᱨᱞᱚᱭ
ᱛᱷᱚᱠ:ᱮᱞᱠᱷᱟ
ᱛᱷᱚᱠ:ᱮᱞ